Key Events This Week
4 May: Week opens at Rs.703.55
6 May: New 52-week high and all-time high reached near Rs.736 and Rs.732 respectively
8 May: Stock hits new 52-week and all-time high of Rs.756
8 May: Week closes at Rs.752.40, up 6.94%

Broad-Based Technical Strength Lifts Granules India Ltd to 52-Week High of Rs 756
2026-05-08 10:35:46With a decisive break above Rs 750, Granules India Ltd has surged to a fresh 52-week high of Rs 756 on 8 May 2026, marking a remarkable 72.25% gain over the past year. This rally is underpinned by a strong alignment of technical indicators and sustained price momentum, even as the broader Sensex trades lower by 0.41%.
Read full news article
Broad-Based Technical Strength Lifts Granules India Ltd to 52-Week High of Rs 736.6
2026-05-06 11:05:13Surging past its previous peaks, Granules India Ltd touched a new 52-week high of Rs 736.6 on 6 May 2026, marking a significant milestone in its price momentum. This rally has been underpinned by a confluence of robust technical indicators and sustained buying interest, setting the stage for a compelling momentum narrative.
Read full news articleGranules India Gains 1.47%: 4 Key Factors Driving the Week’s Momentum
2026-05-02 17:00:49
Key Events This Week
27 Apr: New 52-week high at Rs.699.4
29 Apr: New 52-week high at Rs.713.1 and all-time high at Rs.723
29 Apr: Q4 FY26 results announced with 32.59% profit growth
30 Apr: Week closes at Rs.699.25 (-0.90%)
Are Granules India Ltd latest results good or bad?
2026-04-29 19:14:42Granules India Ltd's latest financial results for Q4 FY26 reveal a strong operational performance characterized by significant growth in both revenue and net profit. The company reported net sales of ₹1,470.61 crores, reflecting a year-on-year increase of 22.81% and a quarter-on-quarter growth of 5.96%. This marks the highest quarterly revenue in the company's recent history, indicating robust demand across its product portfolio. Net profit for the quarter reached ₹201.57 crores, which represents a year-on-year increase of 32.59% and a quarter-on-quarter growth of 34.19%. The operating margin, excluding other income, expanded to 24.16%, up from 21.09% in the same quarter last year, showcasing enhanced operational efficiency and a favorable product mix. Granules India also demonstrated strong capital efficiency with a return on equity (ROE) of 15.81%, positioning it competitively within the pharmaceutical ...
Read full news article
Granules India Q4 FY26: Strong Finish with 32.59% Profit Growth Amid Margin Expansion
2026-04-29 17:45:35Granules India Ltd., a vertically integrated pharmaceutical manufacturer specialising in active pharmaceutical ingredients and finished dosages, delivered a robust fourth-quarter performance for FY26, with consolidated net profit surging 32.59% year-on-year to ₹201.57 crores. The Hyderabad-based company, commanding a market capitalisation of ₹17,625 crores, demonstrated strong operational momentum with sequential profit growth of 34.19% from Q3 FY26, whilst revenue expanded 22.81% year-on-year to ₹1,470.61 crores.
Read full news articleTranscript Of The Earnings Conference Call For Q4 And Financial Year Ended On March 31 2026.
05-May-2026 | Source : BSETranscript of the Earnings Conference Call for Q4 and financial year ended on March 31 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
29-Apr-2026 | Source : BSEAudio Recording of the Investor call
Announcement under Regulation 30 (LODR)-Investor Presentation
29-Apr-2026 | Source : BSEInvestor Presentation
Corporate Actions
No Upcoming Board Meetings
Granules India Ltd has declared 150% dividend, ex-date: 31 Jul 25
Granules India Ltd has announced 1:10 stock split, ex-date: 23 Mar 15
No Bonus history available
No Rights history available









